Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-008136
Filing Date
2016-01-19
Accepted
2016-01-19 16:08:55
Documents
28
Period of Report
2015-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mixx_10q.htm 10-Q 187679
2 CERTIFICATION mixx_ex311.htm EX-31.1 7291
3 CERTIFICATION mixx_ex312.htm EX-31.2 7718
4 CERTIFICATION mixx_ex321.htm EX-32.1 3826
5 CERTIFICATION mixx_ex322.htm EX-32.2 3803
12 img001.jpg GRAPHIC 31152
13 img002.jpg GRAPHIC 19891
14 img003.jpg GRAPHIC 41620
15 img004.jpg GRAPHIC 27064
  Complete submission text file 0001477932-16-008136.txt   928909

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mixx-20151130.xml EX-101.INS 34406
7 XBRL TAXONOMY EXTENSION SCHEMA mixx-20151130.xsd EX-101.SCH 8822
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mixx-20151130_cal.xml EX-101.CAL 32213
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mixx-20151130_def.xml EX-101.DEF 4444
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mixx-20151130_lab.xml EX-101.LAB 89319
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mixx-20151130_pre.xml EX-101.PRE 57829
Mailing Address 10575 N. 114TH SUITE 103 SCOTTSDALE AZ 85259
Business Address 10575 N. 114TH SUITE 103 SCOTTSDALE AZ 85259 480-344-7770
MIX 1 LIFE, INC. (Filer) CIK: 0001501112 (see all company filings)

EIN.: 680678499 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-55422 | Film No.: 161348423
SIC: 2834 Pharmaceutical Preparations